Introduction {#Sec1}
============

Synaptic activity causes release of K^+^ into the extracellular space. The excess K^+^ must be rapidly removed in order to avoid hyperexcitation and epileptic seizures. The mechanisms underpinning K^+^ homeostasis in brain are therefore of critical importance for brain function.

A number of membrane transporters and channels contribute to clearance of K^+^ from the extracellular space. Foremost among these are the Na,K-ATPase, which is responsible for a major fraction of the energy expenditure in brain, and the Kir4.1 inwardly rectifying K^+^ channel (Kofuji and Newman [@CR6]). With the discovery of the brain water channel aquaporin-4 (AQP4), the question arose whether this aquaporin could be involved in K^+^ clearance (Nielsen et al. [@CR9]). This hypothesis was strengthened by the finding that AQP4 was colocalized with Kir4.1 in endfeet of retinal Müller cells (Nagelhus et al. [@CR8]) and that selective removal of AQP4 from endfoot membranes delayed K^+^ clearance following high-frequency activation of hippocampal synapses (Amiry-Moghaddam et al. [@CR1]). Delayed K^+^ clearance was similarly observed following *Aqp4* deletion, albeit only when \[K^+^\]~o~ was mildly increased (Strohschein et al. [@CR11]).

It has long been known that any effect of AQP4 on K^+^ clearance must be indirect, as AQP4 is impermeable to K^+^ and other ions (Nagelhus and Ottersen [@CR7]). Also, removal of AQP4 fails to affect the Kir4.1 conductance under basal conditions (Zhang and Verkman [@CR14]). Some authors have pointed to a possible interaction between AQP4 and the Na,K-ATPase (Illarionova et al. [@CR5]; Strohschein et al. [@CR11]). Adding to the complexity, Strohschein et al. ([@CR11]) showed that *Aqp4* deletion enhances gap-junctional coupling, which would facilitate K^+^ redistribution through the astroglial syncytium.

While several studies have explored the effect of *Aqp4* deletion or AQP4 mislocalization on K^+^ clearance (Amiry-Moghaddam et al. [@CR1]; Padmawar et al. [@CR10]; Binder et al. [@CR2]; Strohschein et al. [@CR11]; Thrane et al. [@CR13]), it remains to resolve whether AQP4 regulates \[K^+^\]~o~ at the synaptic level during afferent stimulation. The importance of this question derives from the finding that *Aqp4* deletion is associated with an increased severity of epileptic seizures (Binder et al. [@CR2]). Here, we show that *Aqp4*^−/−^ animals exhibit a more pronounced \[K^+^\]~o~ peak than wild types during 20 Hz stimulation of Schaffer collateral/commissural fibers. We argue that the increased \[K^+^\]~o~ peak reflects altered volume dynamics during synaptic stimulation.

Materials and methods {#Sec2}
=====================

Animals {#Sec3}
-------

Studies were conducted with adult (8--18 weeks, weighing 20--30 g) constitutive *Aqp4*^−/−^ mice (Thrane et al. [@CR12]) and wild types of both sexes. The experiments comply with Norwegian laws and were approved by the Animal Care and Use Committee of Institute of Basic Medical Sciences, University of Oslo.

Electrophysiology {#Sec4}
-----------------

### Slice preparations {#Sec5}

Wild type and *Aqp4*^−/−^ mice were euthanized with Suprane (Baxter) and brains were removed. Transverse slices (400 μm) from the dorsal and middle portion of each hippocampus, or coronal slices of the cerebrum containing corpus callosum (400 μm), were cut with a vibroslicer in artificial cerebrospinal fluid (ACSF, 4 °C, bubbled with 95 % O~2~ and 5 % CO~2~, containing (in mM): 124 NaCl, 2 KCl, 1.25 KH~2~PO~4~, 2 MgSO~4~, 2 CaCl~2~, 26 NaHCO~3~, and 12 glucose. Both in the resting and interface recording chambers, slices were continuously exposed to humidified gas at 28--32 °C and perfused with ACSF (pH 7.3).

In some of the hippocampal experiments, we applied 50 μM [DL]{.smallcaps}-2-amino-5-phosphonopentanoic acid (AP5; Sigma-Aldrich) and 20 μM 6,7-dinitroquinoxaline-2,3-dione (DNQX; Tocris) to block ionotropic glutamate receptors.

### Stimulation and recording {#Sec6}

Before the experiments, ion-sensitive electrodes were silanized and filled with 150 mM tetramethylammonium chloride (TMA^+^, Sigma Life Sciences). The tips were filled with a liquid K^+^ ion exchanger (IE190; World Precision Instruments) by gentle suction. The electrodes were calibrated by standard solutions of \[K^+^\] (3, 25, 6, 9, and 12 mM). The log-linear fit was used to calculate the \[K^+^\]~o~ from each experiment.

In the hippocampus, orthodromic synaptic stimuli (50 μs, \<300 μA, 0.1 Hz) were delivered through a tungsten electrode situated in stratum radiatum of the CA1 region. The extracellular synaptic responses were monitored by a reference glass electrode (filled with ACSF) placed close to the ion-sensitive electrode in stratum radiatum or stratum pyramidale at a fixed distance (400 µm) from the stimulation electrode (Fig. [2](#Fig2){ref-type="fig"}a, inset). The reference electrode was coupled to the ion-sensitive microelectrode (custom-built differential amplifier, 2 Hz low-pass filter). Thus, the monitored changes in direct current (DC) level reflected the changes in \[K^+^\]~o~.

Following the presence of stable synaptic responses for at least 10 min, we activated the afferent fibers at 20 Hz for 10 s. A similar design was used when eliciting and recording the extracellular prevolley in the corpus callosum. These electrodes were placed on each side of the sagittal line separated at a constant distance (500 µm) (Fig. [2](#Fig2){ref-type="fig"}d, inset).

### Analysis {#Sec7}

A single exponential function (Origin 8) was in each experiment fitted to the \[K^+^\]~o~ decay following the 20 Hz stimulation train. The decay constant was obtained from each experiment.

Data were pooled across mice of the same genotype and are presented as mean ± standard error of the mean (SEM), unless otherwise indicated. For comparison between genotypes, we used a linear mixed model statistical analysis (SAS 9.2), with *p* \< 0.05 being designated as statistically significant.

Fixation and immunocytochemistry {#Sec8}
--------------------------------

After recording, the slices were immersion fixed in 0.1 M phosphate buffer (PB; pH 7.4) containing 4 % formaldehyde (4 °C, over night). The slices were then cryoprotected in sucrose (10, 20, and 30 % in PB) and cut in 15-μm sections on a cryostat. Immunocytochemistry was carried out using an indirect fluorescence method (Nagelhus et al. [@CR8]). The concentrations of the antibodies were: rabbit anti-AQP4 (Millipore) 2 μg/mL and rabbit anti-Kir4.1 (Alomone Labs) 2 μg/mL. Antibodies were diluted in 0.01 M PB with 3 % normal goat serum, 1 % bovine serum albumin, 0.5 % Triton X-100, and 0.05 % sodium azide, pH 7.4. The primary antibodies were revealed by indocarbocyanine (Cy3) coupled to donkey secondary antibody (1:1,000: Jackson ImmunoResearch Laboratories, West Grove, PA) diluted in the same solution as the primary antibodies with the omission of sodium azide. Coronal sections were viewed and photographed with a Zeiss LSM 5 PASCAL microscope equipped with epifluorescence optics, using an M2 filter (BP 546/14, RKP 580, and LP 580) and 40×/1.3 Oil Plan-Neofluar objective.

Results {#Sec9}
=======

AQP4 immunofluorescence of immersion fixed tissue slices revealed a reticular labeling pattern compatible with staining of astrocytic processes in both hippocampus (Fig. [1](#Fig1){ref-type="fig"}a) and corpus callosum (Fig. [1](#Fig1){ref-type="fig"}c). Intense labeling was observed around blood vessels. Absence of AQP4 labeling in *Aqp4*^−*/*−^ mice confirmed the selectivity of antibodies (Fig. [1](#Fig1){ref-type="fig"}e, g). Kir4.1 immunoreactivity in wild type animals resembled that of AQP4, but the signal was weaker around vessels (Fig. [1](#Fig1){ref-type="fig"}b, d). Importantly, the pattern of Kir4.1 immunoreactivity in hippocampus and corpus callosum was unaffected by *Aqp4* deletion (Fig. [1](#Fig1){ref-type="fig"}f, h). The distribution of AQP4 and Kir4.1 labeling of immersion fixed slices was similar to that of perfusion fixed tissue (cf. Haj-Yasein et al. [@CR3]).Fig. 1Distribution of AQP4 and Kir4.1 immunofluorescence in acute slices from hippocampus and corpus callosum. AQP4 labeling in stratum radiatum (*rad*) and stratum pyramidale (*pyr*) of the hippocampal CA1 region (**a**) and in coronal corpus callosum (**c**) from wild type mice. In both regions, a reticular staining pattern was observed, compatible with labeling of fine astrocytic processes. The intense signal around blood vessels corresponds to astrocytic endfeet (*arrowheads*). The selectivity of antibodies was confirmed by absence of AQP4 labeling in slices from *Aqp4* ^−*/*−^ mice **(e**, **g**). Kir4.1 immunofluorescence likewise outlined delicate processes resembling those of astrocytes (**b**, **d**), with less prominent perivascular signal (*arrowhead*) than observed with antibodies against AQP4. Kir4.1 immunoreactivity in hippocampus (**f**) and corpus (**h**) callosum of *Aqp4* ^−*/*−^ mice was similar to that of wild types. *Scale bar* 100 µm

The potassium-sensitive electrodes used to assess extracellular K^+^ dynamics showed voltage responses of 14.8 ± 1.8 mV (mean ± SD, *n* = 45) when \[K^+^\]~o~ was changed from 3.25 to 12 mM (Fig. [2](#Fig2){ref-type="fig"}a, top inset). Stimulation of Schaffer collateral/commissural fibers with parameters (20 Hz, 10 s) identical to those used to reveal effects of *Aqp4* deletion on extracellular volume dynamics (Haj-Yasein et al. [@CR4]) elicited a robust increase in \[K^+^\]~o~ in the CA1 region (Fig. [2](#Fig2){ref-type="fig"}). In stratum radiatum, the peak \[K^+^\]~o~ during stimulation was significantly higher in *Aqp4*^−*/*−^ animals than in wild types, whereas the \[K^+^\]~o~ recovery phase was similar in the two genotypes (Fig. [2](#Fig2){ref-type="fig"}a). In stratum pyramidale, neither peak \[K^+^\]~o~ nor post-stimulation \[K^+^\]~o~ recovery was affected by *Aqp4* deletion (Fig. [2](#Fig2){ref-type="fig"}b). For both genotypes, the peak \[K^+^\]~o~ was higher in stratum pyramidale than in stratum radiatum.Fig. 2Impact of *Aqp4* deletion on extracellular K^+^ dynamics during synaptic stimulation. **a** Potassium responses during and after 10 s stimulation at 20 Hz (*black horizontal bar* along the*abscissa*) from hippocampal synaptic stratum radiatum layer CA1 of wild type (*blue circles*, *n* = 60) and *Aqp4* ^−*/*−^ mice (*red circles*, *n* = 57). *Vertical bars* indicate SEM. *Bracket* indicates period of statistical significant difference (*p* \< 0.05) between genotypes. *Insets* a schematic drawing of the hippocampal formation with recording and stimulating electrodes; electrode calibration graph for the K^+^-sensitive electrodes showing the relationship between voltage and \[K^+^\]~o~ (*bars* indicate SD); histogram of the K^+^-decay constants, measured during the post-stimulation phase (*bars* indicate SEM). **b** As in **a**, but the recordings are from the stratum pyramidale (*n* = 21 for wild type mice, *n* = 25 for *Aqp4* ^−*/*−^ mice). **c** As in **a**, but during blockade of ionotropic glutamate receptors (50 μM AP5 and 20 μM DNQX) thus isolating the changes in \[K^+^\]~o~ mediated by axonal activity. The figure shows that \[K^+^\]~o~ during and after high-frequency stimulation was similar in the two genotypes (*n* = 20 for wild type mice, *n* = 22 for *Aqp4* ^−*/*−^ mice). **d** As in **a**, but experiments were performed on myelinated fibers of the corpus callosum. *Inset* a schematic drawing of the corpus callosum with recording and stimulating electrodes (*n* = 21 for wild type mice, *n* = 23 for *Aqp4* ^−*/*−^ mice)

To resolve whether the effect of *Aqp4* knockout on peak \[K^+^\]~o~ was dependent on postsynaptic K^+^ release mediated through ionotropic glutamate receptor activation, we performed experiments in presence of the NMDA receptor antagonist AP5 (50 μM) and the AMPA receptor antagonist DNQX (20 μM). Deletion of *Aqp4* had no effect on peak \[K^+^\]~o~ under these conditions (Fig. [2](#Fig2){ref-type="fig"}c), where most of the released K^+^ is supposed to derive from unmyelinated axons. Similarly, we failed to detect genotype-dependent differences in \[K^+^\]~o~ kinetics during 20 Hz stimulation of myelinated axons in corpus callosum (Fig. [2](#Fig2){ref-type="fig"}d).

Discussion {#Sec10}
==========

The present data indicate that *Aqp4* deletion leads to a significant increase in peak \[K^+^\]~o~ during synaptic stimulation. The peak was strongly reduced by glutamate receptor blockade, consistent with K^+^ release from postsynaptic sites. The effect of *Aqp4* deletion was restricted to the synaptic layer. Notably, the higher peak recorded at the soma layer was insensitive to *Aqp4* deletion, as was the lower peak recorded in corpus callosum.

This is the first study where the effect of *Aqp4* deletion or AQP4 mislocalization has been investigated in the synaptic termination area of a discrete anatomical pathway. Previous in vivo analyses have investigated the effect of gross cortical stimulation or cortical spreading depression (Padmawar et al. [@CR10]; Binder et al. [@CR2]; Thrane et al. [@CR13]) while earlier studies of the hippocampus have focused on the soma layers (Amiry-Moghaddam et al. [@CR1]; Strohschein et al. [@CR11]).

Post-stimulation recovery of extracellular K^+^ did not differ between *Aqp4*^−/−^ mice and wild types. Thus, the increased peak \[K^+^\]~o~ cannot reflect changes in K^+^ clearance. In agreement, the expression pattern of Kir4.1---which mediates spatial buffering (Haj-Yasein et al. [@CR3])---was not altered by *Aqp4* deletion. Our immunocytochemical data are complementary to the quantitative Western analysis of Zhang and Verkman ([@CR14]) who found no change in Kir4.1 following deletion of *Aqp4*. Membrane potential, barium-sensitive Kir4.1 K^+^ currents, and current--voltage relationship were likewise unchanged, as judged from recordings in freshly isolated glial cells.

The most salient explanation is that *Aqp4* deletion affects peak \[K^+^\]~o~ via changes in extracellular volume dynamics. This would be in line with our recent report (Haj-Yasein et al. [@CR4]). During a stimulation paradigm identical to the present, *Aqp4*^−/−^ animals showed a more pronounced extracellular space shrinkage than did wild type animals. Indeed, the effect on volume (Haj-Yasein et al. [@CR4]) mimicked the effect on \[K^+^\]~o~ (present study), in regard to both time course and amplitude. Also, the effects of *Aqp4* deletion on volume and \[K^+^\]~o~ share the same layer specificity in that they occur in stratum radiatum but not in stratum pyramidale. This bolsters the idea that the effect of *Aqp4* gene deletion on peak \[K^+^\]~o~ is secondary to volume changes. The alternative explanation, that peak \[K^+^\]~o~ was increased due to enhanced excitability and K^+^ release, finds no support in previous studies (Amiry-Moghaddam et al. [@CR1]; Haj-Yasein et al. [@CR4]).

Analyses in slices allow precise stimulation of defined pathways and are compatible with strict control of metabolic status. Previous analyses that have demonstrated an effect of *Aqp4* deletion on extracellular K^+^ recovery were done in vivo following gross stimulations that easily could have depleted the tissue of energy substrates, thus affecting Na,K-ATPase-dependent K^+^ recovery (Padmawar et al. [@CR10]; Binder et al. [@CR2]; Thrane et al. [@CR13]). Previous slice studies indicating an effect on clearance used genetic or stimulation paradigms that differed from those used here (Amiry-Moghaddam et al. [@CR1]; Strohschein et al. [@CR11]).

The present study shows that *Aqp4* deletion has a layer-specific effect on \[K^+^\]~o~ that precisely mirrors the reported effect on extracellular volume dynamics. When *Aqp4* is deleted, the stimulation induced \[K^+^\]~o~ will be accentuated as a direct consequence of the loss of volume homeostasis. The mechanism proposed here might explain the increase in seizure severity that is observed in animals with mislocalization or depletion of AQP4 (Amiry-Moghaddam et al. [@CR1]; Binder et al. [@CR2]).
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